Latest NFAT Stories
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.
LA JOLLA, Calif., June 23 /PRNewswire/ -- CalciMedica announced the appointment of Steven L. Schoenfeld, MD, as Vice President, Clinical Development. Dr. Schoenfeld's successful, clinical drug development career spans over 20 years in the pharmaceutical and biotechnology industries.
LA JOLLA, Calif., Feb. 16 /PRNewswire/ -- CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel.
Scientists from A*STAR's Singapore Immunology Network (SIgN) and the University of Milano-Bicocca, Italy, have discovered another signaling pathway for the activation and apoptosis, or programmed cell death, of dendritic cell
- The governor of a province or people.